-
Mashup Score: 40Online Event - 2 month(s) ago
Three-dimensional (3D) cell culture technologies, such as organoids, boomed over the past decade. As such, precision medicine, the tailoring of disease prevention and treatment based on a patient’s genes, environment, and lifestyle, is getting closer to becoming a reality for more and more diseases. First applied in the customized treatment of individual cystic fibrosis patients in 2016, organoids are now being considered for cancers as well as neurodegenerative diseases. Last year organoids were even
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 39Online Event - 2 month(s) ago
Three-dimensional (3D) cell culture technologies, such as organoids, boomed over the past decade. As such, precision medicine, the tailoring of disease prevention and treatment based on a patient’s genes, environment, and lifestyle, is getting closer to becoming a reality for more and more diseases. First applied in the customized treatment of individual cystic fibrosis patients in 2016, organoids are now being considered for cancers as well as neurodegenerative diseases. Last year organoids were even
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 28Online Event - 3 month(s) ago
While cancer remains a formidable challenge, accounting for one out of every six deaths globally, the past decade has seen leaps in our collective understanding of the basic science of cancer as well as treatment approaches. Many of these advances stem from innovative strategies for pursuing the big questions in cancer. In 2016, Cancer Grand Challenges named its inaugural cohort of teams, each set against one of the most vexing problems in cancer research of the time: mapping tumors in 3D, differentiating
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 28Online Event - 3 month(s) ago
While cancer remains a formidable challenge, accounting for one out of every six deaths globally, the past decade has seen leaps in our collective understanding of the basic science of cancer as well as treatment approaches. Many of these advances stem from innovative strategies for pursuing the big questions in cancer. In 2016, Cancer Grand Challenges named its inaugural cohort of teams, each set against one of the most vexing problems in cancer research of the time: mapping tumors in 3D, differentiating
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 18Online Event - 3 month(s) ago
With today’s new generation of cloud-based high performance computing (HPC) and AI tools, researchers in computational chemistry and materials science are scaling and accelerating efforts that could address some of our world’s toughest challenges. While there are few concrete examples of computational discoveries that have been validated experimentally, a shift is finally starting to take place. In this special session, experts from Microsoft and Pacific Northwest National Laboratory will share some of
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16Online Event - 5 month(s) ago
The drive to push exploration of what we know about life is an inspiration to pursue science. However, while the research forefront keeps pushing the boundaries of what is possible, structures for scientific career paths have stagnated. Traditionally, life science career paths in research are standardized and focused on either the traditional academic or industrial route. Yet a shift is underway, as researchers begin to recognize the value in a new way of doing science. By harnessing different types of
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 27Online Event - 6 month(s) ago
Genomics is a fast-moving field that is revolutionizing the way we understand biology. To continue to accelerate discovery in this space, and to make genomics advances accessible throughout the world, an education infrastructure that integrates skills development and networking opportunities is needed. Intentionally building connections between scientists through educational programs is key to driving innovation, particularly in emerging research fields. In this Science Webinar, experts will discuss their
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16Online Event - 6 month(s) ago
By many measures, this is a golden age of drug discovery, particularly for rare diseases. In 2022, more than half of the novel drugs approved by the U. S. Food and Drug Administration were for patients with rare disease. Many of these treatments represent modalities at the cutting edge of medicine. With genomics advances offering pathways to personalized medicine and artificial intelligence transforming pharmaceutical research, people with rare diseases have reason to hope. Yet, in too many cases, condition
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 58Online Event - 6 month(s) ago
By some estimates, 96% of experimental drugs fail to make it to market. Not only does this mean that people are left without life-saving medications, but scientists are wasting an enormous amount of time and resources on dead-end projects. New methods are needed to make the drug development process more efficient. Cancer immunotherapy has emerged as a game-changer in the fight against cancer, harnessing the power of the immune system to target and destroy cancer cells. However, the road to developing
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 18Online Event - 6 month(s) ago
Science Webinars is pleased to welcome Robert M. Califf, Commissioner of Food and Drugs at the United States Food and Drug Administration (FDA), for a Fireside Chat about the intersection between the FDA and rare disease. This intimate and enlightening conversation will provide unique insights into the challenges and opportunities faced by individuals and organizations dedicated to advancing research and treatment options for rare diseases. While each rare disease may affect only a small percentage of the
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
Join #ScienceWebinars for their next #technology broadcast on Wednesday, 20 March at 12 p.m. ET ➡️ It's personal: Organoids leading the charge in precision medicine. Register today: https://t.co/2v902B9YND https://t.co/RSsEgEyMBu